- Home
- IBCP vs PRME Comparison
IBCP vs PRME Comparison
Compare IBCP & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBCP
- PRME
- Stock Information
- Founded
- IBCP 1864
- PRME 2019
- Country
- IBCP United States
- PRME United States
- Employees
- IBCP N/A
- PRME N/A
- Industry
- IBCP Major Banks
- PRME Medicinal Chemicals and Botanical Products
- Sector
- IBCP Finance
- PRME Health Care
- Exchange
- IBCP Nasdaq
- PRME Nasdaq
- Market Cap
- IBCP 682.2M
- PRME 601.1M
- IPO Year
- IBCP N/A
- PRME 2022
- Fundamental
- Price
- IBCP $30.85
- PRME $3.49
- Analyst Decision
- IBCP Hold
- PRME Buy
- Analyst Count
- IBCP 3
- PRME 6
- Target Price
- IBCP $36.00
- PRME $9.31
- AVG Volume (30 Days)
- IBCP 113.3K
- PRME 3.9M
- Earning Date
- IBCP 10-28-2025
- PRME 11-07-2025
- Dividend Yield
- IBCP 3.35%
- PRME N/A
- EPS Growth
- IBCP 10.56
- PRME N/A
- EPS
- IBCP 3.25
- PRME N/A
- Revenue
- IBCP $222,890,000.00
- PRME $5,977,000.00
- Revenue This Year
- IBCP N/A
- PRME $179.58
- Revenue Next Year
- IBCP $12.21
- PRME N/A
- P/E Ratio
- IBCP $9.56
- PRME N/A
- Revenue Growth
- IBCP 7.05
- PRME 647.13
- 52 Week Low
- IBCP $26.75
- PRME $1.11
- 52 Week High
- IBCP $40.32
- PRME $6.94
- Technical
- Relative Strength Index (RSI)
- IBCP 44.83
- PRME 36.62
- Support Level
- IBCP $30.46
- PRME $3.17
- Resistance Level
- IBCP $31.38
- PRME $4.00
- Average True Range (ATR)
- IBCP 0.65
- PRME 0.40
- MACD
- IBCP 0.02
- PRME -0.12
- Stochastic Oscillator
- IBCP 46.31
- PRME 14.29
About IBCP Independent Bank Corporation
Independent Bank Corp (Ionia MI) operates as a commercial bank. It offers a broad range of banking services to individuals and businesses, including checking and savings accounts, commercial lending, direct and indirect consumer financing, mortgage lending, and safe deposit box services. It also provides internet and mobile banking capabilities to its customers.
About PRME Prime Medicine Inc.
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.